DTU Logo
Overview | 4-T | ACE | ADOPT | AFORRD | DREAM | EDIT | EXSCEL | FHS | GLINT | ISAT | LDS | NAVIGATOR | TECOS | UKPDS

Treating To Target in Type 2 Diabetes (Completed)



The Treating To Target in Type 2 diabetes (4-T) study was a three-year, multi-centre, open-label, randomised, parallel-group trial comparing the safety and efficacy of three different analogue insulin treatment regimens in 700 participants with Type 2 diabetes inadequately controlled by oral therapy.

The trial was funded by an unrestricted educational grant from Novo Nordisk